Active Ingredient: APROCITENTAN
Proprietary Name: TRYVIO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217686
Product Number: 001
Approval Date: Mar 19, 2024
Applicant Holder Full Name: IDORSIA PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
